Recce Pharmaceuticals Announces Investor Webinar on Clinical Developments and Global Commercialisation Strategy
Recce Pharmaceuticals Ltd (ASX: RCE), a pharmaceutical company developing a new class of synthetic anti-infectives, announced a live investor webinar scheduled for 21 July 2026. The online event will feature presentations from senior leadership including Chief Medical Advisor Dr Alan W. Dunton, Chairman Dr John Prendergast, and Chief Executive Officer James Graham, who will provide shareholders with updates on the company's clinical programs, regulatory initiatives, and global commercialisation strategy.
- July 21, 2026 12:33 PM AEST
- Anjali Anand
Acrux Limited Secures Shareholder Approval for Capital Raise, Options Issuance, and Executive Equity at July 2026 EGM
Acrux Limited (ASX:ACR), a specialty pharmaceutical company with 25 years of experience in developing and commercialising topically applied products, has successfully passed all seven resolutions at its Extraordinary General Meeting held on 21 July 2026. The resolutions, decided by poll, secured shareholder approval for a placement capital raise, options issuances, and executive equity acquisitions, with support levels ranging from 88 to 94 percent across the various measures.
- July 21, 2026 12:33 PM AEST
- Mukul
Klevo Rewards (KLV) to Execute 10-for-1 Share Consolidation Pending Shareholder Vote on August 21, 2026
Klevo Rewards Limited (KLV) announced a security consolidation on a 10-for-1 basis, subject to shareholder approval at a general meeting scheduled for 21 August 2026. The company will consolidate its ordinary fully paid shares and multiple option series, reducing the total number of ordinary shares on issue from approximately 1.54 billion to around 154.5 million. The reorganisation aims to streamline the company's capital structure and is set to commence trading on a deferred settlement basis from 25 August 2026, with normal trading resuming on 3 September 2026.
- July 21, 2026 12:33 PM AEST
- Shwetambri Chauhan
Flagship Minerals Secures Full US$4 Million Payment for RK Lithium Project Sale, Advances Gold and Copper Focus
Flagship Minerals Limited (ASX:FLG) has received the full US$4 million (~A$5.8 million) cash consideration from the sale of its 100% owned RK Lithium Project in southern Thailand, following execution of a binding Sale and Purchase Agreement in June 2026. The company is now advancing its transition to a Gold and Copper focused explorer and developer, with discussions underway for the sale of its Khao Soon Tungsten Project and plans to progress the 2.1 million ounce Isidora Gold Project in Chile to feasibility stage.
- July 21, 2026 12:33 PM AEST
- Shwetambri Chauhan
Perpetual Credit Income Trust Announces Net Tangible Asset Value of $1.098 per Unit as of July 20, 2026
Perpetual Credit Income Trust (ASX: PCI) has released its daily Net Tangible Asset estimate, reporting a unit value of $1.098 as at close of business on 20 July 2026. The trust, managed by Perpetual Investment Management Limited, provides investors with regular updates on unit valuations to support transparency in its credit-focused investment strategy. The announcement reflects the trust's ongoing portfolio management activities within the fixed-income and credit markets.
- July 21, 2026 12:33 PM AEST
- Sonal Goyal
Recce Pharmaceuticals Expands MENA Reach with Exclusive Distribution Deal and Advances Diabetic Foot Infection Treatment to Phase 3
Recce Pharmaceuticals Ltd (ASX: RCE) has entered a non-binding term sheet with a leading Middle Eastern pharmaceutical company for exclusive distribution rights to its RECCE® 327 Topical Gel (R327G) across the MENA region, with potential upfront and milestone payments totalling up to USD $3.5 million. The company has also secured Human Research Ethics Committee (HREC) approval to advance its Australian clinical trial of R327G to a pivotal Phase 3 study for diabetic foot infections, whilst successfully passing a comprehensive regulatory inspection by Indonesia's national drug authority. A recent institutional placement raised A$4.0 million at A$0.40 per share, bringing the pro-forma cash position to approximately A$33.1 million.
- July 21, 2026 12:33 PM AEST
- Sonal Goyal
What Keeps AGL (ASX:AGL) at the Centre of Grid Transition?
AGL is attracting attention as Australia's electricity market evolves through grid transition, rising power demand, operational discipline and changing customer requirements, keeping generation flexibility central to today's energy sector discussion.
- July 21, 2026 12:30 PM AEST
- Sam
Why Is Origin (ASX:ORG) Back in the Energy Security Lens?
Origin remains central to Australia’s energy-security debate as gas supply, retail demand, affordability, generation reliability and cash conversion shape assessments of operating flexibility and financial discipline today.
- July 21, 2026 12:29 PM AEST
- Sam
Why Is Woodside (ASX:WDS) Leading the Energy Debate Now?
Woodside remains a key focus as the Australian market evaluates energy security, cash-flow resilience, disciplined project execution and operational consistency amid commodity volatility and a more selective reporting-season environment.
- July 21, 2026 12:28 PM AEST
- Sam
ANZ Group (ASX:ANZ): Why Are Income Markets Watching Closely?
ANZ is back in focus as franked income, credit quality, margin discipline, funding stability and capital strength shape Australia’s increasingly selective banking and dividend conversation today.
- July 21, 2026 12:21 PM AEST
- Sam